Page 778 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition

756 PART IV Specific Malignancies in the Small Animal Patient

169. Lana S, Plaza S, Hampe K, et al.: Diagnosis of mediastinal masses 190. Comazzi S, Avery PR, Garden OA, et al.: European canine lym-
in dogs by flow cytometry, J Vet Intern Med 20:1161–1165, 2006. phoma network consensus recommendations for reporting flow
170. Tasca S, Carli E, Caldin M, et al.: Hematologic abnormalities and cytometry in canine hematopoietic neoplasms, Cytometry Part B
VetBooks.ir flow cytometric immunophenotyping results in dogs with hemato- 191. Fournel-Fleury C, Magnol JP, Bricaire P, et al.: Cytohistological
92:411–419, 2017.
poietic neoplasia: 210 cases (2002-2006), Vet Clin Pathol 38:2–12,
2009.
171. Vail DM, Kravis LD, Kisseberth WC, et al.: Application of rapid and immunological classification of canine malignant lympho-
mas: comparison with human non-Hodgkin’s lymphomas, J Comp
CD3 immunophenotype analysis and argyrophilic nucleolar orga- Pathol 117:35–59, 1997.
nizer region (AgNOR) frequency to fine needle aspirate specimens 192. Ponce F, Magnol JP, Marchal T, et al.: High-grade canine T-cell
from dogs with lymphoma, Vet Clin Pathol 26:66–69, 1997. lymphoma/leukemia with plasmacytoid morphology: a clinical
172. Bauer NB, Zervos D, Moritz A: Argyrophilic nucleolar organiz- pathological study of nine cases, J Vet Diagn Invest 15:330–337,
ing regions and Ki67 equally reflect proliferation in fine needle 2003.
aspirates of normal, hyperplastic, inflamed, and neoplastic canine 193. Keller SM, Vernau W, Moore PF: Clonality testing in veterinary
lymph nodes (n = 101), J Vet Intern Med 21:928–935, 2007. medicine: a review with diagnostic guidelines, Vet Pathol 53:711–
173. Fournel-Fleury C, Magnol JP, Chabanne L, et al.: Growth fractions 725, 2016.
in canine non-Hodgkin’s lymphomas as determined in situ by the 194. Langner KF, Joetzke AE, Nerschbach V, et al.: Detection of clonal
expression of the Ki-67 antigen, J Comp Pathol 117:61–72, 1997. antigen receptor gene rearrangement in dogs with lymphoma by
174. Phillips BS, Kass PH, Naydan DK, et al.: Apoptotic and proliferation real-time polymerase chain reaction and melting curve analysis,
indexes in canine lymphoma, J Vet Diagn Invest 12:111–117, 2000. BMC Vet Res 10(1), 2014.
175. Vajdovich P, Psader R, Toth ZA, et al.: Use of the argyrophilic 195. Waugh EM, Gallagher A, Haining H, et al.: Optimisation and vali-
nucleolar region method for cytologic and histologic examination dation of a PCR for antigen receptor rearrangement (PARR) assay
of the lymph nodes in dogs, Vet Pathol 41:338–345, 2004. to detect clonality in canine lymphoid malignancies, Vet Immunol
176. Hung LC, Pong VF, Cheng CR, et al.: An improved system for Immunopathol 182:115–124, 2016.
quantifying AgNOR and PCNA in canine tumors, Anticancer Res 196. Bergman PJ, Ogilvie GK, Powers BE: Monoclonal antibody C219
20:3273–3280, 2000. immunohistochemistry against P-glycoprotein: sequential analysis
177. Poggi A, Miniscalco B, Morello E, et al.: Prognostic significance of and predictive ability in dogs with lymphoma, J Vet Intern Med
Ki67 evaluated by flow cytometry in dogs with high-grade B-cell 10:354–359, 1996.
lymphoma, Vet Comp Oncol 15:431–440, 2017. 197. Moore AS, Leveille CR, Reimann KA, et al.: The expression of
178. Frantz AM, Sarver AL, Ito D, et al.: Molecular profiling reveals P-glycoprotein in canine lymphoma and its association with multi-
prognostically significant subtypes of canine lymphoma, Vet Pathol drug resistance, Cancer Invest 13:475–479, 1995.
50:693–703, 2013. 198. Gaines PJ, Powell TD, Walmsley SJ, et al.: Identification of serum
179. Su Y, Nielsen D, Zhu L, et al.: Gene selection and cancer type clas- biomarkers for canine B-cell lymphoma by use of surface-enhanced
sification of diffuse large-B-cell lymphoma using a bivariate mix- laser desorption-ionization time-of-flight mass spectrometry, Am J
ture model for two-species data, Hum Genomics 7(2), 2013. Vet Res 68:405–410, 2007.
180. Avery A: Molecular diagnostics of hematologic malignancies, Top 199. McCaw DL, Chan AS, Stegner AL, et al.: Proteomics of canine
Companion Anim Med 24:144–150, 2009. lymphoma identifies potential cancer-specific protein markers, Clin
181. Avery PR, Avery AC: Molecular methods to distinguish reactive Cancer Res 13:2496–2503, 2007.
and neoplastic lymphocyte expansions and their importance in 200. Ratcliffe L, Mian S, Slater K, et al.: Proteomic identification and
transitional neoplastic states, Vet Clin Pathol 33:196–207, 2004. profiling of canine lymphoma patients, Vet Comp Oncol 7:92–105,
182. Burnett RC, Vernau W, Modiano JF, et al.: Diagnosis of canine 2009.
lymphoid neoplasia using clonal rearrangements of antigen recep- 201. Wilson CR, Regnier FE, Knapp DW, et al.: Glycoproteomic pro-
tor genes, Vet Pathol 40:32–41, 2003. filing of serum peptides in canine lymphoma and transitional cell
183. Dreitz MJ, Ogilvie G, Sim GK: Rearranged T lymphocyte antigen carcinoma, Vet Comp Oncol 6:171–181, 2008.
receptor genes as markers of malignant T cells, Vet Immunol Immu- 202. Bryan JN: The current state of clinical application of serum bio-
nopathol 69:113–119, 1999. markers for canine lymphoma, Frontie Vet Sci 3:87, 2016.
184. Gentilini F, Calzolari C, Turba ME, et al.: GeneScanning analysis 203. Alexandrakis I, Tuli R, Ractliffe SC, et al.: Utility of a multiple
of Ig/TCR gene rearrangements to detect clonality in canine lym- serum biomarker test to monitor remission status and relapse in
phomas, Vet Immunol Immunopathol 127:47–56, 2009. dogs with lymphoma undergoing treatment with chemotherapy,
185. Keller RL, Avery AC, Burnett RC, et al.: Detection of neoplastic Vet Comp Oncol 15:6–17, 2017.
lymphocytes in peripheral blood of dogs with lymphoma by poly- 204. Mirkes EM, Alexandrakis I, Slater K, et al.: Computational diag-
merase chain reaction for antigen receptor gene rearrangement, Vet nosis and risk evaluation for canine lymphoma, Comput Biol Med
Clin Pathol 33:145–149, 2004. 53:279–290, 2014.
186. Tamura K, Yagihara H, Isotani M, et al.: Development of the poly- 205. Selting KA, Ringold R, Husbands B, et al.: Thymidine kinase
merase chain reaction assay based on the canine genome database type 1 and C-reactive protein concentrations in dogs with spon-
for detection of monoclonality in B cell lymphoma, Vet Immunol taneously occurring cancer, J Vet Intern Med 30:1159–1166,
Immunopathol 110:163–167, 2006. 2016.
187. Yagihara H, Tamura K, Isotani M, et al.: Genomic organization 206. Sharif H, von Euler H, Westberg S, et al.: A sensitive and kineti-
of the T-cell receptor gamma gene and PCR detection of its clonal cally defined radiochemical assay for canine and human serum thy-
rearrangement in canine T-cell lymphoma/leukemia, Vet Immunol midine kinase 1 (TK1) to monitor canine malignant lymphoma,
Immunopathol 115:375–382, 2007. Vet J 194:40–47, 2012.
188. Davis B, Schwartz M, Duchemin D, et al.: Validation of a mul- 207. Hahn KA, Freeman KP, Barnhill MA, et al.: Serum alpha 1-acid
tiplexed gene signature assay for diagnosis of canine cancers from glycoprotein concentrations before and after relapse in dogs
formalin-fixed paraffin-embedded tissues, J Vet Intern Med 31:854– with lymphoma treated with doxorubicin, J Am Vet Med Assoc
863, 2017. 214:1023–1025, 1999.
189. Drazovska M, Sivikova K, Dianovsky J, et al.: Comparative genomic 208. Kazmierski KJ, Ogilvie GK, Fettman MJ, et al.: Serum zinc, chro-
hybridization in detection of DNA changes in canine lymphomas, mium, and iron concentrations in dogs with lymphoma and osteo-
An Sci J 88:27–32, 2017. sarcoma, J Vet Intern Med 15:585–588, 2001.